11/4/2024Hangzhou Reprogenix Secures Over CNY 100M in Series A Funding, Advanci...

11/1/2024Shanghai Unveils Initiative to Boost Local Biopharma's Global Expansio...

11/1/2024Global Biotech Supply Chain: A Shift Away from China and Opportunities...

11/1/2024Merck Faces Gardasil Sales Challenges in China, Impact Expected to Con...

11/1/2024Hengrui Pharma Weighs Hong Kong IPO to Drive Global Expansion

11/1/2024U.S. Drugmakers Seek Alternatives to Chinese Supply Chains Amid Rising...

10/31/2024Biostar Pharma Debutx on the Hong Kong Stock Exchange

10/30/2024Eli Lilly's Weight-Loss Drug Mounjaro Set to Debut in Hong Kong

10/29/2024GSK Acquires CMG1A46 from Chimagen Biosciences to Expand Immunology P...

10/28/2024Baxter Halts Intravenous Therapy Operations in China Amid Market Chall...

10/28/2024Cytoship Secures Angel Funding to Advance Cutting-Edge Delivery Vector...

10/28/2024USFDA Clears RiboX's IND for Circular RNA Therapy RXRG001

10/28/2024Innovent's Subsidiary Fortvita Secures Strategic Investment in $20.5M ...

10/25/2024Everest Medicines Launches VELSIPITY(R) in the Guangdong-HK-Macau Grea...

10/24/2024China's Innovative Drug Industry Faces Pricing Pressures Amid Steady D...

10/24/2024Beijing Biostar Advances Lead Oncology Asset with $41M Hong Kong IPO

10/24/2024Sinopharm and Chinese Vaccine Makers Slash Prices Amid Fierce Market C...

10/24/2024Wuhan Hongchen Bio Secures CNY Tens of Mlns in Angel Round Financing, ...

10/24/2024Legend Biotech Abandons Genscript as Majority Shareholder Amid Geopoli...

10/24/2024Hengrui Pharma Considering Second Listing in Hong Kong

10/24/2024Eccogene Receives $60M ilestone Payment from AstraZeneca Following Do...

10/24/2024Hope Medicine Announces Positive Results from a Global Phase 2 Study o...

10/23/2024Guangzhou Aims to Establish Itself as a Global Biopharmaceutical Hub

10/22/2024ArkBio's Ziresovir Set to Transform RSV Treatment in China

10/22/2024Takeda: China to Emerge as Its Second-Largest Market by 2031

10/22/2024XellSmart RaisesCNY 100M+ in Series B1 Financing for iPS-Derived Cell ...

10/22/2024siRNA Developer Rigerna Secures CNY100M+ in Series Angel+ Funding

10/22/2024Bristol Ends LaNova Partnership on Claudin18.2 ADC, Eyes Potential I-M...

10/22/2024Oricell's IND for MSLN/Claudin 18.2 Dual CAR-T Therapy Cleared in Chin...

10/21/2024Innovent's IBI3001 Receives Approval for Clinical Trials in China for ...

Page:12/21 Total number of articles:605: [First][<<] [10] [11] [12] [13] [14] [>>] [End]